Aggravation of atonic seizures by rufinamide: A case report.

Bektas G., Caliskan M., Aydin A., Yildiz E., Tatli B., Aydinli N., ...Daha Fazla

Brain & development, cilt.38, sa.7, ss.654-7, 2016 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 38 Sayı: 7
  • Basım Tarihi: 2016
  • Doi Numarası: 10.1016/j.braindev.2016.02.005
  • Dergi Adı: Brain & development
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.654-7
  • İstanbul Üniversitesi Adresli: Evet

Özet

Background: Rufinamide is a novel antiepileptic drug used as adjunctive therapy in patients with Lennox-Gastaut syndrome and provides seizure control especially in tonic and atonic seizures. Rufinamide is expected to be effective in intractable epilepsy when atonic and tonic seizures exist. However, rufinamide induced seizure aggravation has been reported in a few patients, which was not associated with a specific type of seizure.